Company Filing History:
Years Active: 2019
Title: Yvonne Alice Nagel: Innovator in Insulin Receptor Modulators
Introduction
Yvonne Alice Nagel is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of stabilized polypeptide insulin receptor modulators. Her innovative work has the potential to impact the treatment of diabetic conditions.
Latest Patents
Yvonne holds a patent for "Stabilized polypeptide insulin receptor modulators." This patent describes stabilized α-CT polypeptides that comprise an alpha-helical segment. The polypeptides are designed to bind to the insulin receptor and include at least one staple or stitch, which consists of cross-linked amino acids. The patent also covers insulin analogs that incorporate these stapled or stitched α-CT polypeptides, along with pharmaceutical compositions and methods for treating diabetes and its complications.
Career Highlights
Yvonne is affiliated with Harvard College, where she conducts her research and development work. Her dedication to advancing medical science is evident in her innovative approaches to insulin receptor modulation.
Collaborations
Yvonne has collaborated with notable colleagues, including Gregory Lawrence Verdine and Gerard Hilinski. These partnerships have likely contributed to her success in the field of biochemistry and patent development.
Conclusion
Yvonne Alice Nagel is a trailblazer in the realm of insulin receptor modulators, with her patent showcasing her innovative spirit and commitment to improving diabetes treatment. Her work continues to inspire advancements in medical science.